Avanos director granted 12,003 cash-settled RSUs

OLEARY PATRICK J reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

OLEARY PATRICK J reported acquisition or exercise transactions in this Form 4 filing.

AVANOS MEDICAL, INC. director Patrick J. O’Leary received a grant of 12,003 restricted share units on May 8, 2026 as compensation. Each unit represents a contingent right to a cash payment equal to the value of one share of Avanos common stock.

These units were issued to replace restricted share units originally granted on January 2, 2025. The award vests when O’Leary’s service on the company’s Board of Directors ends, meaning the units are long-term, service-based compensation rather than an immediate cash payout.

Insider Trade Summary

Grant/Award: 12,003 shares

Grant/Award 1 txn

Insider OLEARY PATRICK J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Units	12,003	$0.00	$0.00

Holdings After Transaction: Restricted Share Units — 12,003 contracts (Direct)

Footnotes (2)

1. F1. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025.
2. F2. The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors.

Key Figures

RSU grant size: 12,003 units Exercise price: $0.0000 per unit Units after transaction: 12,003 units

3 metrics

RSU grant size 12,003 units Restricted share units granted May 8, 2026

Exercise price $0.0000 per unit Grant/award acquisition, compensation not purchased

Units after transaction 12,003 units Total restricted share units following this grant

Key Terms

Restricted Share Units, contingent right, vest, Board of Directors

4 terms

Restricted Share Units financial

"Represents restricted share units issued to the Reporting Person on May 8, 2026."

Restricted share units (RSUs) are a promise from a company to give an employee or service provider actual shares or cash equal to the shares after certain conditions are met, typically staying with the company for a set time or hitting performance targets. Think of them like a time-locked gift card that becomes usable only after you’ve earned it. For investors, RSUs matter because they align employee incentives with company performance and can increase the number of shares outstanding over time, diluting existing ownership and affecting earnings per share.

contingent right financial

"Each restricted share unit represents a contingent right to receive a cash payment"

vest financial

"The restricted share units vest on the date the Reporting Person terminates service"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Board of Directors financial

"vest on the date the Reporting Person terminates service on the Issuer's Board of Directors."

The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AVANOS MEDICAL (AVNS) report for Patrick J. O’Leary?

AVANOS MEDICAL (AVNS) reported that director Patrick J. O’Leary received 12,003 restricted share units on May 8, 2026. These units are part of his board compensation and are linked to the value of Avanos common stock rather than being an open-market stock purchase.

Are the 12,003 units in the AVNS Form 4 actual Avanos Medical shares?

The 12,003 units are not actual shares of AVANOS MEDICAL (AVNS) stock. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of Avanos common stock, rather than delivering stock itself.

When do Patrick J. O’Leary’s AVNS restricted share units vest?

Patrick J. O’Leary’s AVANOS MEDICAL (AVNS) restricted share units vest when he terminates service on the company’s Board of Directors. This structure ties the compensation to the length of his board service and encourages continued service over time.

Why did AVANOS MEDICAL (AVNS) issue new restricted share units to replace earlier ones?

AVANOS MEDICAL (AVNS) issued the 12,003 restricted share units to replace units originally granted on January 2, 2025. The filing explains they are replacement awards, indicating an adjustment to prior compensation rather than a separate, incremental grant.

Does the AVNS Form 4 show Patrick J. O’Leary buying or selling Avanos shares?

The AVANOS MEDICAL (AVNS) Form 4 does not show O’Leary buying or selling shares on the market. It records a compensation-related acquisition of 12,003 restricted share units, granted at no exercise price, with settlement in cash based on Avanos share value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 11:37 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OLEARY PATRICK J

(Last) (First) (Middle)

5405 WINDWARD PARKWAY

(Street)

ALPHARETTA GEORGIA 30004

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Units	(1)	05/08/2026		A		12,003		(2)	(2)	Common Stock	12,003	$0	12,003	D

Explanation of Responses:

1. Represents restricted share units issued to the Reporting Person on May 8, 2026. Each restricted share unit represents a contingent right to receive a cash payment equal to the value of one share of the Issuer's common stock. The restricted share units were issued to replace the restricted share units issued to the Reporting Person on January 2, 2025.

2. The restricted share units vest on the date the Reporting Person terminates service on the Issuer's Board of Directors.

Remarks:

	/s/ John Fischer, as attorney-in-fact for Patrick J. O'Leary	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)